Fundraising Fox
/People
Sign in

Jakob Dupont

Investor

Partner at Sofinnova Ventures · Board director at Apexigen

Boston, Massachusetts, United States

Find your path to Jakob

441 people in our graph can introduce you to Jakob.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Pascal Touchon to introduce you to Jakob

You →Pascal · together at Atara Biotherapeutics (2020–2023) →Jakob

Ask Jamie Chen to introduce you to Jakob

You →Jamie · 11 people · together at Genentech →Jakob

Sign up to find every way you can get introduced to Jakob

  • Your email: the people you already email who know Jakob
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Jakob
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Jakob Dupont is a physician with over two decades of experience in oncology and other therapeutic areas, focused on developing therapies for high unmet medical needs. Before joining Sofinnova in 2023, he held senior R&D and medical leadership roles at Atara Biotherapeutics, Gossamer Bio, Genentech/Roche, and OncoMed Pharmaceuticals. He earned his M.D. from Cornell University's Weill Medical College and an M.A. in philosophy from New York University, and completed his oncology fellowship at Memorial Sloan Kettering Cancer Center.

Contact· self-published, not guessed

Invests in

Biotech

Board director at Apexigen

Intro paths

→

In turn, Jakob can intro founders to Apexigen's investors below.

Apexigen's investors · 6

3E Bioventures CapitalPalo Alto · since 2018Decheng CapitalMenlo Park · since 2018EFung CapitalShenzhen · since 2019ShangBay Capital LLCPalo Alto · since 2019Sv Tech Ventures, Inc.Palo Alto · since 2018Virtus Inspire Venturessince 2018

Co-founders at Apexigen

XY
Xiaodong YangPresident, CEO and Secretary

Experience

  1. Sofinnova InvestmentsExecutive Partnercurrent2023 — presentMenlo Park, California, United States
  2. OnCusp TherapeuticsBoard Observercurrent2025 — presentNew York, New York, United States
  3. Bolt Biotherapeutics, Inc.Member Board of Directorscurrent2024 — presentRedwood City, California, United States
  4. Avenzo TherapeuticsMember Board of Directorscurrent2024 — presentSan Diego Metropolitan Area
  5. Pyxis OncologyMember Board of Directorscurrent2023 — presentBoston, MA
  6. Imugene LimitedNon Executive Directorcurrent2022 — presentSydney, New South Wales, Australia
  7. Pioneering MedicinesScientific Advisory Boardcurrent2023 — presentBoston, Massachusetts, United States
  8. VC UniversityMentorcurrent2025 — present
  9. The University of Texas Medical BranchAdvisory Board Membercurrent2025 — presentGalveston, Texas, United States
  10. AmbrxScientific Advisory Board2021 — 2024San Diego, California, United States
  11. Atara BiotherapeuticsConsultant2023
  12. Atara BiotherapeuticsGlobal Head of Research & Development and EVP2020 — 2023South San Francisco, California, United States
  13. ApexigenIndependent Director2020 — 2023San Carlos, California, United States
  14. Gossamer BioConsultant Oncologist2020 — 2021San Diego, California, United States
  15. Gossamer BioChief Medical Officer2018 — 2020San Diego, California
  16. GenentechVice President, Global Head Breast and Gynecologic Cancer Development2017 — 2018South San Francisco, California
  17. Stanford University School of MedicineAdjunct Clinical Faculty: Medical Oncology2009 — 2018Stanford, California, USA
  18. OncoMed PharmaceuticalsChief Medical Officer and SVP2011 — 2016Redwood City, California, USA
  19. RocheGlobal Medical Director, Avastin2011Basel Area, Switzerland
  20. GenentechDirector: Early and Late Stage Development2006 — 2010South San Francisco, California, USA
  21. Memorial Sloan Kettering Cancer CenterResearcher: Tumor Immunology2006Human Oncology and Pathogenesis Program (HOPP)
  22. Memorial Sloan Kettering Cancer CenterResearcher: The Laboratory of Bone Marrow Transplantation (PI: Richard O'Reilly)2002 — 2006
  23. Memorial Sloan Kettering Cancer CenterAssistant Member2001 — 2006
  24. Memorial Sloan Kettering Cancer CenterResearch Fellow: The Laboratory of Gene Transfer and Gene Expression (PI: Michel Sadelain)2000 — 2002The Laboratory of Gene Transfer and Gene Expression (PI: Michel Sadelain)
  25. Weill Cornell Medical CollegeAssistant Professor2001 — 2006

Skills & more

CTMS1Oncology99Clinical Development99Biotechnology52Clinical Trials91Cancer73Clinical Research99Drug Development59Biomarkers6Molecular Biology5Biopharmaceuticals5Lifesciences8
+10 moreDrug DiscoveryMedical AffairsPharmaceutical IndustryGCPImmunologyHematologyMedical WritingInfectious DiseasesMedicinePharmacovigilance

Languages Danish · English · French (some) · German (some)

  • Medical Oncology — American Board of Internal Medicine
  • Internal Medicine — American Board of Internal Medicine

From Jakob's professional profile.

Investments

Board seats

AvenzoBolt (BOLT)OnCusp

Per the firm's website.

Colleagues at Sofinnova Ventures

Alex Chan
Controller, Private Equity at Sofinnova Ventures
Alex Dulnev
IT Manager at Sofinnova Ventures
Amanda Phillips
Executive Assistant at Sofinnova Ventures
Anastasia Voevodin
Analyst, Public Equity at Sofinnova Ventures
Aneal Tenjarla
Partner, Associate Portfolio Manager, Public Equity at Sofinnova Ventures
Calvin Sternick
Analyst, Public Equity at Sofinnova Ventures
Chris Carpenter
Executive Partner, Private Equity at Sofinnova Ventures
Daniel Ni, MD, PhD
Analyst, Public Equity at Sofinnova Ventures

Frequently asked questions

Who is Jakob Dupont?
Jakob Dupont is a physician with over two decades of experience in oncology and other therapeutic areas, focused on developing therapies for high unmet medical needs. Before joining Sofinnova in 2023, he held senior R&D and medical leadership roles at Atara Biotherapeutics, Gossamer Bio, Genentech/Roche, and OncoMed Pharmaceuticals. He earned his M.D. from Cornell University's Weill Medical College and an M.A. in philosophy from New York University, and completed his oncology fellowship at Memorial Sloan Kettering Cancer Center.
Where does Jakob Dupont work?
Jakob Dupont is Partner at Sofinnova Ventures and Board director at Apexigen.
What does Jakob Dupont invest in?
Jakob Dupont invests in Biotech.
What boards does Jakob Dupont sit on?
Jakob Dupont holds tracked board seats at Avenzo, Bolt (BOLT), OnCusp.
Where did Jakob Dupont go to school?
Jakob Dupont studied at Memorial Sloan Kettering Cancer Center (Fellowship, Medical Oncology); Joan & Sanford I. Weill Medical College of Cornell University (Residency, Internal Medicine); University of Michigan Medical School (Internship, Internal Medicine).

Same school

Shared employers